Literature DB >> 15961136

Liver injury and viremia in mice infected with dengue-2 virus.

M V Paes1, A T Pinhão, D F Barreto, S M Costa, M P Oliveira, A C Nogueira, C M Takiya, J C Farias-Filho, H G Schatzmayr, A M B Alves, O M Barth.   

Abstract

The goal of this study was to test the feasibility of BALB/c mice as an experimental model in the study of dengue disease. BALB/c mice were intraperitoneal infected with DENV-2 obtained from a human patient. Histopathological analysis of infected animals revealed liver injury with viral antigens detection. In initial stages, the most prominent lesions were vacuolization and diffuse steatosis in hepatocytes. Serum levels of ALT and AST increased progressively, reaching the highest values 7 days p.i. and decreasing at the 14th day. Since levels of circulating virus were very low, viremia was analyzed in C6/36 cells. Virus presence was detected by ultrastructural analysis, confirmed by RT-PCR assays. Period of viremia was analyzed by flow cytometry with cells incubated with mouse-infected sera collected in different days, revealing peak virus levels at the 7th day p.i. All such data correlate to the development of the disease described in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961136     DOI: 10.1016/j.virol.2005.04.042

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  49 in total

Review 1.  Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis.

Authors:  Karen Clyde; Jennifer L Kyle; Eva Harris
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

Review 2.  Endothelial cells in dengue hemorrhagic fever.

Authors:  Anon Srikiatkhachorn; James F Kelley
Journal:  Antiviral Res       Date:  2014-07-12       Impact factor: 5.970

3.  Report of an NIAID workshop on dengue animal models.

Authors:  M Cristina Cassetti; Anna Durbin; Eva Harris; Rebeca Rico-Hesse; John Roehrig; Alan Rothman; Stephen Whitehead; Ramya Natarajan; Catherine Laughlin
Journal:  Vaccine       Date:  2010-04-29       Impact factor: 3.641

4.  Experimental inoculation of Artibeus jamaicensis bats with dengue virus serotypes 1 or 4 showed no evidence of sustained replication.

Authors:  Salomé Cabrera-Romo; Benito Recio-Tótoro; Ana C Alcalá; Humberto Lanz; Rosa María del Ángel; Victor Sánchez-Cordero; Ángel Rodríguez-Moreno; Juan E Ludert
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

5.  Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.

Authors:  Satoru Watanabe; Kitti Wing Ki Chan; Jiaqi Wang; Laura Rivino; Shee-Mei Lok; Subhash G Vasudevan
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

6.  Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence.

Authors:  David A Stein; Stuart T Perry; Michael D Buck; Christopher S Oehmen; Matthew A Fischer; Elizabeth Poore; Jessica L Smith; Alissa M Lancaster; Alec J Hirsch; Mark K Slifka; Jay A Nelson; Sujan Shresta; Klaus Früh
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

Review 7.  Mouse models of dengue virus infection and disease.

Authors:  Lauren E Yauch; Sujan Shresta
Journal:  Antiviral Res       Date:  2008-07-09       Impact factor: 5.970

Review 8.  Dengue virus pathogenesis: an integrated view.

Authors:  Byron E E Martina; Penelope Koraka; Albert D M E Osterhaus
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 9.  Dengue vaccines: recent developments, ongoing challenges and current candidates.

Authors:  Monica A McArthur; Marcelo B Sztein; Robert Edelman
Journal:  Expert Rev Vaccines       Date:  2013-08       Impact factor: 5.217

10.  Dengue virus capsid protein usurps lipid droplets for viral particle formation.

Authors:  Marcelo M Samsa; Juan A Mondotte; Nestor G Iglesias; Iranaia Assunção-Miranda; Giselle Barbosa-Lima; Andrea T Da Poian; Patricia T Bozza; Andrea V Gamarnik
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.